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Abstract
Introduction: Shared decision making is not always commonplace in advanced colo‐
rectal	or	lung	cancer	care.	Decision	aids	(DAs)	might	be	helpful.	This	review	aimed	(a)	
to	provide	an	overview	of	DAs	for	patients	with	advanced	colorectal	or	lung	cancer	
and assess their availability; and (b) to assess their effectiveness if possible.
Methods: A	 systematic	 literature	 search	 (PubMed/EMBASE/PsycINFO/CINAHL)	











be effective in advanced colorectal or lung cancer. Rigorous testing of the effects of 
currently	available	and	future	DAs,	to	improve	patient	outcomes,	is	urgently	needed.
K E Y W O R D S
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1  | INTRODUC TION
Colorectal and lung cancer are common types of cancer (new world‐
wide cases in 2018: 1.8 and 2.1 million respectively) with—depending 
on	the	tumour	stage—unfavourable	prognoses	(International	Agency	
for	Research	on	Cancer,	2018a,	2018b).	Patients	for	whom	curative	





Shared decision making is an approach in which patients and cli‐
nicians	 discuss	 the	 best	 available	 evidence	when	 facing	 decisions,	
while patients are assisted in expressing their preferences and be‐





Halpern,	 Squiers,	 Treiman,	&	McCormack,	 2014).	 It	 is	 appreciated	
by	 many	 patients	 (Degner	 &	 Sloan,	 1992;	 Keating,	 Guadagnoli,	
Landrum,	 Borbas,	 &	Weeks,	 2002)	 and	 has	 been	 associated	 with	
positive	patient	outcomes,	such	as	increased	knowledge	about	the	










DAs	 are	 tools	 that	 help	 patients	 to	 come	 to	 the	 best	 decision	 by	
showing	the	available	options	(treatment	and	care	options),	clarify‐
ing personal values and providing information about the available 





patients	 form	more	 stable	 preferences	 (Pieterse	 et	 al.,	 2011),	 im‐
proves	their	knowledge	and	awareness	of	treatment	options	(Austin,	










or lung cancer and assess their availability; and (b) to assess their 
effectiveness if possible.
2  | METHODS













relevant would have been found through the Internet search and 
when	consulting	the	experts,	or	through	manual	searching	of	refer‐
ence	 lists.	The	search	strategy	(Appendix	1)	was	developed	in	col‐
laboration with an experienced librarian and checked by an expert in 
the	field	(Glyn	Elwyn).	A	manual	search	of	reference	lists	of	the	arti‐
cles included was conducted to identify additional relevant articles.
2.1.2 | Internet search and consultation of experts
The Internet search and expert consultation complemented the sys‐
tematic	 literature	 search,	 as	we	hypothesised	 that	not	all	 the	DAs	
might	 have	 been	 published	 in	 peer‐reviewed	 journals	 (or	 not	 yet).	










and	 the	USA)	 and	Dutch	 SDM,	 colorectal	 cancer	 and	 lung	 cancer	
experts (n	=	13).	They	were	identified	via	core	articles	or	through	the	




     |  3 of 14SPRONK et al.
Original	 empirical	 published	 studies,	 written	 in	 any	 language,	
were included if they focused on:




on (a) providing information about current options; (b) current de‐
cision making processes; or (c) helping patients by eliciting prefer‐
ences for current treatment options.
Comparison:	for	our	second	research	question,	that	is	the	effective‐






2.2.2 | Internet search and consultation of experts
The same patient and intervention inclusion criteria were applied as 
for	 the	 systematic	 literature	 search.	However,	we	anticipated	 that	
the comparison and outcome inclusion criteria would not apply.
2.3 | Study selection and data extraction
2.3.1 | Systematic literature search
One researcher (IS) performed the search and removed duplicates. 
Two	researchers	(IS	and	LvV)	independently	screened	15%	of	the	re‐
cords	based	on	title	and	abstract.	The	overlap	was	100%,	so	the	ad‐
ditional records were screened by a single researcher (IS). In the case 
of	any	doubt,	the	record	was	included	and	screened	by	two	authors	
independently	during	full‐text	screening.	Full‐text	screening	and	ex‐
traction of data was done independently by two researchers (IS and 





present).	 In	the	case	where	a	DA	was	not	 included	 in	the	article,	or	
not	 found	 on	 the	 Internet,	 the	 authors/developers	were	 contacted	
about	its	status	and	asked	to	send	the	researchers	a	copy	of	the	DA.	
Disagreements arising from decisions around article inclusion or the 
extraction	of	data	were	discussed	with	a	third	researcher	(LvV).	When	
consensus	was	not	reached	with	the	third	author,	the	research	team	
was involved and the issue was discussed until consensus was reached.
2.3.2 | Internet search and consultation of experts
The Internet search was carried out by one researcher (IS). Potentially 
relevant	 DAs	 were	 selected	 and	 independently	 screened	 by	 two	
researchers	 (IS	 and	MH/LvV).	 DAs	 provided	 by	 the	 experts	 were	
handled in the same way. The data extraction followed the same 
steps as used in the systematic literature search.
2.4 | Quality assessment
2.4.1 | Quality of included studies
As	 the	 included	 studies	 used	 different	 designs,	 their	 quality	 was	
assessed	with	the	quality	assessment	 tool	of	Hawker,	Payne,	Kerr,	
Hardey,	and	Powell	(2002).	This	tool	includes	nine	domains:	abstract	
and title; introduction and aims; method and data; sampling; data 
analysis; ethics and bias; results; transferability and implications/
usefulness.	 Following	 Hawker	 et	 al.	 (2002),	 each	 domain	 was	 as‐
sessed	for	each	study,	with	scores	ranging	from	1	(“very	poor”)	to	4	







2.4.2 | Level of evidence DAs included
To	 assess	 the	 level	 of	 evidence	 of	 the	 DAs,	 the	 Grading	 of	
Recommendations	 Assessment,	 Development	 and	 Evaluation	
(GRADE)	methodology	was	used	(Guyatt	et	al.,	2008).	GRADE	clas‐
sifies	evidence	into	four	quality	levels	(high,	moderate,	low	and	very	
low). Studies were classified based on their design. Randomised 
control	 trials	 (RCTs)	 get	 a	 high‐quality	 initial	 grade	 and	 observa‐
tional	studies	a	low‐quality	initial	grade.	These	initial	grades	can	be	




and opposing residual confounding or bias are criteria for upgrad‐
ing.	Based	on	the	upgrading	and	downgrading	criteria,	the	final	evi‐
dence grade was independently determined by two researchers (IS 
and	MH).	Disagreements	were	 resolved	by	discussion	with	a	 third	
researcher	(LvV).
2.4.3 | Effectiveness of the DAs included
To	 evaluate	 the	 effectiveness	 of	 the	 DAs,	 “part	 III	 Effectiveness”	
of	the	International	Patient	Decision	Aid	Standards	(IPDAS)	criteria	
for	judging	the	quality	of	patient	DAs	was	used	(Elwyn	et	al.,	2006).	
This part consists of seven items. These items include assessment 
of	whether	 the	DA	 helps	 patients	 (a)	 to	 recognise	 that	 a	 decision	
needs to be made; (b) to know the options and their features; (c) 
to understand that values affect the decision; (d) to be clear about 
which features of the options matter most; (e) to discuss values with 
their	practitioner,	6)	 to	become	 involved	 in	 the	patients’	preferred	
4 of 14  |     SPRONK et al.
way; and (g) to improve the match between the chosen option and 











Internet	 search	 revealed	 two	 relevant	 DAs	 and	 the	 experts	 sug‐
gested	six	DAs.	Four	of	these	eight	DAs	had	not	been	identified	by	
the systematic search and were therefore added (Figure 1).
Table	1	gives	an	overview	of	the	main	characteristics	of	all	DAs	




for	 advanced	 lung	 cancer	 patients	 (DuBenske,	 Gustafson,	 Shaw,	




Netherlands,	 four	 in	the	USA,	one	 in	Singapore,	one	 in	Japan,	and	
one	was	developed	by	collaborating	researchers	from	both	Australia	
and	Canada.	All	the	DAs	had	been	developed	to	be	used	by	patients	
before the consultation; none were designed to be used during the 
consultation.	Only	one	DA	(Meropol	et	al.,	2013)	engaged	the	clini‐
cian,	who	received	a	summary	report	of	the	patient's	responses	that	
could then be used during the consultation.
3.1 | Colorectal cancer DAs
All	 four	 of	 the	 DAs	 for	 patients	 with	 advanced	 colorectal	 cancer	
are	 still	 available.	 Two	 DAs	 included	 booklets	 presenting	 options	
for	 supportive	 care	 with	 or	 without	 first‐line	 (Leighl	 et	 al.,	 2011)	




2017),	 and	 the	 fourth	DA	 (Decision	aid	MLDS)	 (Maag	Lever	Darm	
Stichting	 (Dutch	 digestive	 disease	 foundation),	 2016)	 is	 a	 website	
(including videos) about patients’ value clarification in the palliative 




et	 al.,	 2017)	 (Table	2).	 Patients	 receiving	 the	DA	on	 first‐line	 che‐
motherapy	(Leighl	et	al.,	2011)	demonstrated	higher	overall	under‐
standing of the prognoses but satisfaction was similar to the control 
group	 (quality:	 good,	GRADE:	moderate,	 IPDAS:	6/7).	Patients	 re‐
ceiving	 the	 DA	 on	 second‐line	 chemotherapy	 (Oostendorp	 et	 al.,	
2017)	were	no	less	anxious	and	did	not	perceive	better	well‐being	
compared	 to	 the	 control	 group	 (quality:	 good,	GRADE:	moderate,	
IPDAS:	3/7).	A	 third	DA	 (Enzinger	et	 al.,	 2017)	was	developed	 for	
F I G U R E  1   Flow chart of the inclusion 
of	decision	aids	(DAs)












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8 of 14  |     SPRONK et al.
advanced	colorectal	cancer	patients.	It	was,	however,	not	evaluated	




oped	 and	 that	 describes	 characteristics,	 side	 effects	 and	 differ‐
ences between surgery and radiotherapy; it assists patients in 




sisted of a booklet for stage 4 lung cancer patients (Steendam et 
al.,	2016)	about	the	potential	treatment	options	(including	chemo‐
therapy,	immunotherapy	and	experimental	studies)	versus	support‐
ive	 care	without	 anti‐cancer	 therapy.	The	DA	of	DuBenske	et	 al.	
(2010)	(CHESS)	is	no	longer	available.	This	DA	comprised	an	inter‐
active communication system to bridge the communication gaps 
that	occur	between	patients,	families	and	clinicians	in	cancer	care	
in	order	to	enhance	SDM.
The	 effectiveness	 of	 two	 out	 of	 the	 four	 DAs	 was	 tested	
(DuBenske	 et	 al.,	 2010;	 Tang	 et	 al.,	 2008),	 although	 they	 differed	
substantially	 in	 terms	of	 study	design,	 content	 and	outcome	mea‐
sures.	The	CHESS	DA	(DuBenske	et	al.,	2010)	was	tested	in	an	RCT	
and compared against a control group that received standard care 
and	had	access	to	the	Internet.	Using	CHESS	resulted	in	significantly	
lower distress in patients (p	=	0.031;	quality:	fair,	GRADE:	moderate,	
IPDAS:	6/7).	The	decision	board	(Tang	et	al.,	2008)	was	tested	in	an	
observational study with a suboptimal design that had no control 
group and in which the description of the outcome measures was 
deficient.	Evaluation	showed	that	all	patients	(100%)	were	satisfied	
with	 being	 involved	 in	 the	 decision	 making	 process	 (quality:	 fair,	
GRADE:	very	low,	IPDAS:	5/7).
3.3 | Generic DAs used by colorectal and lung 
cancer patients
The	four	other	DAs	were	generic	for	all	cancer	types	but	were	used	





value	 clarification	 (currently	 being	 evaluated)	 (Henselmans	 et	 al.,	
2018)	 or	 a	 booklet	 with	 tables	 including	 information	 about	 first‐,	
second‐,	 third‐	 and	 fourth‐line	 chemotherapy	 (Smith	 et	 al.,	 2011).	
The	CONNECT	DA	(Meropol	et	al.,	2013)	is	not	available	anymore.	
This	DA	was	 a	 communication	 aid	 for	 patients	 and	 assessed	 their	
values,	goals	and	communication	preferences,	alongside	communi‐
cation	skills	training.	This	was	the	only	DA	identified	that	engaged	
the healthcare provider by providing them with a summary report of 
the patient's responses.
Three	of	the	generic	DAs	were	evaluated.	Two	were	tested	in	an	




while making it easier to reach decisions compared to standard care 
(quality:	good,	GRADE:	low,	IPDAS	7/7).	Patients	rated	the	materials	
of	the	DA	of	Shirai	et	al.	(2012)	as	useful,	but	the	DA	did	not	lead	to	
statistically	 significant	differences	 in	 the	overall	numbers	of	ques‐
tions	posed	and	the	frequency	of	questions	compared	to	standard	
care	 (quality:	 good,	GRADE:	moderate,	 IPDAS:	 3/7).	 The	 informa‐
tion	tables	(Smith	et	al.,	2011)	were	felt	to	be	helpful	(74%).	Patients	
were	willing	 to	 complete	 the	DA	 (96%)	 and	 share	 the	 information	
















Our systematic review first illustrates that there is a lack of read‐
ily	available	DAs	for	use	in	advanced	colorectal	and	lung	cancer	care.	




were	 still	 in	 the	development	or	 testing	phase	 (Henselmans	et	 al.,	
2018;	MAASTRO	clinic,	2018)	and	another	was	over	a	decade	old	
and	no	update	seems	to	have	occurred	(Tang	et	al.,	2008).	Whether	
or not the other tools were updated after publication remains un‐
clear.	This	might	be	problematic,	as	guidelines	change	over	time	and	
more evidence about the recommended treatment of choice may 
become	available.	Moreover,	two	of	the	DAs	that	improved	patient	
outcomes	such	as	physical	distress	(DuBenske	et	al.,	2010)	and	de‐
cision	 making/communication	 satisfaction	 (Meropol	 et	 al.,	 2013)	
were	no	 longer	available	due	to	a	 lack	of	funding	to	keep	the	DAs	
available and up to date (personal communication). These results are 
in	 line	with	 two	 related,	 recently	 published	 systematic	 reviews	 of	
DAs	in	advanced	breast	and	other	cancers	(Spronk,	Burgers,	et	al.,	
2018;	 Tapp	&	Blais,	 2018),	which	 also	 found	 few	 available,	 up‐to‐
date	DAs.	For	example,	 four	out	of	 the	 sixteen	 identified	DAs	 for	
     |  9 of 14SPRONK et al.








they have demonstrated the ability to improve patient outcomes. 
Our	systematic	review	provided	little	unequivocal	evidence	that	this	
is the case in advanced colorectal and lung cancer patients. Some 
positive	effects	were	found,	 for	example	on	subjective	knowledge	
(Oostendorp	 et	 al.,	 2017),	 prognostic	 understanding	 (Leighl	 et	 al.,	
2011),	 and	 satisfaction	 with	 communication	 and	 decision	 making	
(Meropol	et	al.,	2013).	Many	of	the	outcomes	studied,	however,	re‐
mained	unaffected	and	the	quality	of	the	evidence	was	suboptimal,	





important to ascertain that their use is not harmful. We found that 










practice and policy further.
Several recommendations can be made for optimising the de‐
velopment	 and	 evaluation	 of	 current	 and	 future	DAs	 in	 advanced	
colorectal	and	lung	cancer	care.	First,	improvements	of	current	DAs	
and	development	of	future	DAs	should	preferably	be	done	in	collab‐
oration with national and international medical and physicians’ as‐
sociations,	which	also	take	ownership	and	responsibility	for	keeping	
the	DAs	up	 to	 date.	Using	 the	best	 available	 evidence	 and	 guide‐
lines	(like	IPDAS)	to	provide	information	for	the	development	phase	
should	also	improve	the	quality	of	DAs	(Durand	et	al.,	2015;	Elwyn	






antee	SDM	 (Hargraves	&	Montori,	 2014;	Stiggelbout	et	 al.,	 2012).	
Focusing	on	the	link	between	SDM	and	patient	outcomes,	SDM	in	
colorectal or lung cancer (irrespective of patients’ preferences for 
SDM)	 improves	 the	 evaluated	 quality	 of	 received	 communication	
and	provided	care	from	the	patient's	perspective	(Kehl	et	al.,	2015).	
In	 other	 settings,	 tools	 (e.g.,	 Option	 Grids)	 have	 been	 developed	
that can be used by the patient and clinician together during a clin‐
ical	visit	to	ensure	SDM	and	to	improve	patient	outcomes	(Breslin,	
Mullan,	&	Montori,	2008;	Elwyn	et	al.,	2013).	Such	tools	might	be	
useful	 for	 improving	 SDM	and	patient	 outcomes	 in	 advanced	 col‐
orectal	 and	 lung	 cancer	 care.	 Third,	 according	 to	 an	 expert	 group	
of	 clinicians,	 researchers	 and	 patient	 representatives	 (Spronk,	 van	
Dulmen,	Heins,	&	van	Vliet,	2018),	several	preconditions	at	the	level	
of	the	organisation	(e.g.,	enough	time	(Legare	et	al.,	2008),	profes‐




patient associations need to be involved from development through 




hensive	 overview,	 including	 all	 languages	 and	 the	 fact	 that	 a	 sys‐
tematic literature search was conducted alongside an Internet and 
expert inventory. Four medical and social science databases were 
searched using a systematic search strategy that was developed 
in collaboration with an experienced librarian and checked by an 
expert	 in	the	field.	A	 limitation	 is	 that	only	some	of	the	DAs	were	
evaluated and that we did not assess patients’ and clinicians’ views 
on	the	included	DAs.	In	addition,	the	title/abstract	screening	of	our	










skewed	 the	 results.	 Limitations	 at	 the	 outcome	 level	 include	 the	






onstrated positive effects on patient outcomes in advanced colo‐
rectal or lung cancer. Rigorous testing is needed of the effects of 
DAs	that	have	not	yet	been	tested	in	proper	designs	(possibly	after	
updating),	DAs	that	are	currently	under	development,	and	DAs	that	
may be developed in the future. Such initiatives are urgently needed 
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